Launching a CDMO in Brazil aiming to develop biopharmaceuticals for clinical trials

The innovation timeline is expensive, risky, competitive, time-consuming, and labor-intensive. In order to overcome such challenges and optimize financial resources, pharmaceutical companies nowadays hire contract development and manufacturing organizations (CDMO) to help them. Based on the experien...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Rui Seabra, Morales, Marcelo Marcos, Barretti, Pasqual, Barraviera, Benedito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Estudos de Venenos e Animais Peçonhentos (CEVAP/UNESP) 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171928/
https://www.ncbi.nlm.nih.gov/pubmed/35721790
http://dx.doi.org/10.1590/1678-9199-JVATITD-2022-0017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171928/
https://www.ncbi.nlm.nih.gov/pubmed/35721790
http://dx.doi.org/10.1590/1678-9199-JVATITD-2022-0017

Ejemplares similares